FIELD: medicine.
SUBSTANCE: application of hypoglycemic agent as nateglinide for treating affected glucose metabolism for the purpose to prevent or deteriorate the onset of pronounced non-insulin dependent diabetes mellitus or prevent or deteriorate the onset of other manifestations of affected glucose metabolism. The innovation proves nateglinide's capacity to restore early phase of insulin secretion, that is it should be applied as an intensifier of insulin secretion.
EFFECT: higher efficiency of application.
7 cl, 5 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING METABOLISM DISORDERS MAINLY DIABETES CASES AND DISEASES OR STATES RELATED TO DIABETES | 2000 |
|
RU2280447C2 |
| METHODS OF DIACEREIN APPLICATION IN ADDITIONAL TREATMENT OF DIABETES | 2011 |
|
RU2563988C2 |
| COMBINATIONS AND COMPOSITIONS CONTAINING FATTY ACIDS AND AMINO ACIDS, THEIR APPLICATION FOR PREVENTION AND DELAY OF PROGRESSING OR TREATMENT OF DIABETES AND DIABETES ASSOCIATED DISEASES AND CONDITIONS, METHOD OF WEIGHT REDUCTION IN MAMMAL, KIT | 2004 |
|
RU2356247C2 |
| THE NUTRITIONAL COMPOSITIONS ON THE BASIS OF THE EXTRACT OF TOUTI AND METHODS OF THEIR APPLICATION | 2007 |
|
RU2442602C2 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION OF PROLONGED ACTION | 2011 |
|
RU2465896C2 |
| APPLICATION OF DPP-IV INHIBITOR FOR REDUCTION OF GLYCEMIA ACUTE EXACERBATION | 2006 |
|
RU2440143C2 |
| COMBINED THERAPY WITH GPR119 AGONISTS AND DPP-4 INHIBITORS | 2020 |
|
RU2818562C2 |
| METHOD OF TREATING METABOLIC SYNDROME WITH USING DOPAMINE RECEPTOR AGONISTS | 2008 |
|
RU2473344C2 |
| COMPOSITIONS AND METHODS FOR TREATING DIABETES | 2004 |
|
RU2367423C2 |
| METHOD FOR METABOLIC SYNDROME TREATMENT USING DOPAMINE RECEPTOR AGONISTS | 2012 |
|
RU2624232C2 |
